Stuart Therapeutics

Stuart Therapeutics is a biotechnology company that offers PolyCol, a therapeutic platform for ophthalmic indications. PolyCol’s unique method of action results in accelerated healing and recovery in various ophthalmic disease states and offers a new way to address indications such as dry eye disease, dry age related macular degeneration, and glaucoma. PolyCol is based on patented research from a major U.S. university, combined with additional intellectual property acquired by Stuart Therapeutics. The company has developed applications for PolyCol in treating certain ophthalmic, gastrointestinal, inflammatory, and oncology conditions.

Stuart Therapeutics is the only Biotechnology company we track in Space Coast — one of 32 across Florida.